GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Gross Margin %

Galderma Group AG (XSWX:GALD) Gross Margin % : 69.90% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Galderma Group AG's Gross Profit for the six months ended in Jun. 2024 was CHF1,384 Mil. Galderma Group AG's Revenue for the six months ended in Jun. 2024 was CHF1,981 Mil. Therefore, Galderma Group AG's Gross Margin % for the quarter that ended in Jun. 2024 was 69.90%.


The historical rank and industry rank for Galderma Group AG's Gross Margin % or its related term are showing as below:

XSWX:GALD' s Gross Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 69.9
Current: 69.9

During the past 0 years, the highest Gross Margin % of Galderma Group AG was 69.90%. The lowest was 0.00%. And the median was 0.00%.

XSWX:GALD's Gross Margin % is ranked better than
83.08% of 969 companies
in the Drug Manufacturers industry
Industry Median: 47.02 vs XSWX:GALD: 69.90

Galderma Group AG had a gross margin of 69.90% for the quarter that ended in Jun. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Galderma Group AG was 0.00% per year.

Galderma Group AG Gross Margin % Historical Data

The historical data trend for Galderma Group AG's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Gross Margin % Chart

Galderma Group AG Annual Data
Trend
Gross Margin %

Galderma Group AG Semi-Annual Data
Jun23 Jun24
Gross Margin % 71.02 69.90

Competitive Comparison of Galderma Group AG's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galderma Group AG's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's Gross Margin % falls into.


Galderma Group AG Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Galderma Group AG's Gross Margin for the fiscal year that ended in . 20 is calculated as

Gross Margin % (A: . 20 )=Gross Profit (A: . 20 ) / Revenue (A: . 20 )
=0 /
=(Revenue - Cost of Goods Sold) / Revenue
=( - ) /
=N/A %

Galderma Group AG's Gross Margin for the quarter that ended in Jun. 2024 is calculated as


Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=1384.5 / 1980.661
=(Revenue - Cost of Goods Sold) / Revenue
=(1980.661 - 596.165) / 1980.661
=69.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Galderma Group AG  (XSWX:GALD) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Galderma Group AG had a gross margin of 69.90% for the quarter that ended in Jun. 2024 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Galderma Group AG Gross Margin % Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Gross Margin %
Comparable Companies
Traded in Other Exchanges
GALDY:USA GDERF:USA GALDz:UK
Address
Zahlerweg 10, Zug, CHE, 6300
Website
https://www.galderma.com
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines